1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors.
Saved in:
| Title: | 1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors. |
|---|---|
| Authors: | Marron, T.U.1 (AUTHOR), Misleh, J.G.2 (AUTHOR), C. chen3 (AUTHOR), Wainberg, Z.A.4 (AUTHOR), Powderly, J.5 (AUTHOR), Boccia, R.6 (AUTHOR), Gordon, M.7 (AUTHOR), Segar, J.8 (AUTHOR), Csiki, I.9 (AUTHOR), Schanzer, J.M.10 (AUTHOR), O'Toole, L.11 (AUTHOR), Huang, N.9 (AUTHOR), Seppa, J.9 (AUTHOR), Glenn, J.12 (AUTHOR), Klumpp, K.13 (AUTHOR), Spira, A.I.14 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS623-S624. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173098961 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Marron%2C+T%2EU%2E%22">Marron, T.U.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Misleh%2C+J%2EG%2E%22">Misleh, J.G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22C%2E+chen%22">C. chen</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wainberg%2C+Z%2EA%2E%22">Wainberg, Z.A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powderly%2C+J%2E%22">Powderly, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boccia%2C+R%2E%22">Boccia, R.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gordon%2C+M%2E%22">Gordon, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Segar%2C+J%2E%22">Segar, J.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Csiki%2C+I%2E%22">Csiki, I.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schanzer%2C+J%2EM%2E%22">Schanzer, J.M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22O'Toole%2C+L%2E%22">O'Toole, L.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+N%2E%22">Huang, N.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seppa%2C+J%2E%22">Seppa, J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glenn%2C+J%2E%22">Glenn, J.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klumpp%2C+K%2E%22">Klumpp, K.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spira%2C+A%2EI%2E%22">Spira, A.I.</searchLink><relatesTo>14</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS623-S624. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173098961 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2164 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S623 Titles: – TitleFull: 1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Marron, T.U. – PersonEntity: Name: NameFull: Misleh, J.G. – PersonEntity: Name: NameFull: C. chen – PersonEntity: Name: NameFull: Wainberg, Z.A. – PersonEntity: Name: NameFull: Powderly, J. – PersonEntity: Name: NameFull: Boccia, R. – PersonEntity: Name: NameFull: Gordon, M. – PersonEntity: Name: NameFull: Segar, J. – PersonEntity: Name: NameFull: Csiki, I. – PersonEntity: Name: NameFull: Schanzer, J.M. – PersonEntity: Name: NameFull: O'Toole, L. – PersonEntity: Name: NameFull: Huang, N. – PersonEntity: Name: NameFull: Seppa, J. – PersonEntity: Name: NameFull: Glenn, J. – PersonEntity: Name: NameFull: Klumpp, K. – PersonEntity: Name: NameFull: Spira, A.I. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |